- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01175265
Effects of Breathing Retraining in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Effects of Breathing Retraining on Pulmonary Function, Exercise Capacity, Quality of Life and Cardiac Autonomic Function in Patients With COPD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To address this uncertainty, we performed a randomized controlled trial to assess the effects of a 4-week rehabilitation program including breathing retraining on pulmonary function (PFT), cardio-pulmonary exercise capacity (CPET), health related quality of life (HRQL) and cardiac autonomic modulation (CAM).
A randomized controlled trial comparing the effects of a conventional 4-week pulmonary rehabilitation program with those of a 4-week pulmonary rehabilitation program plus breathing retraining on pulmonary function (FEV1), cardiopulmonary exercise capacity (6-minute walking distance, 6MWD), health related quality of life (chronic respiratory questionnaire, CRQ) and cardiac autonomic function (rMSSD) was performed.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Nordrheinwestfalen
-
Essen, Nordrheinwestfalen, Germany, 45239
- University Hospital Ruhrlandklinik
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinically stable patients with COPD (GOLD-classification I-IV)
Exclusion Criteria:
- Patients with clinical signs of COPD exacerbation
- Cardiac arrhythmia
- Coronary artery disease
- Primary pulmonary vascular disease
- Oxygen desaturation to less than 80% during exercise on room air
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: pulmonary rehabilitation, no breathing retraining
Forty COPD patients (23 females) with a mean (SD) age of 66.0 (6.3) years and a FEV1 of 47.1 (18.9) % predicted were randomized to conventional pulmonary rehabilitation (n=20) and conventional pulmonary rehabilitation plus breathing retraining (n=20).
|
|
|
No Intervention: breathing retraining
Forty COPD patients (23 females) with a mean (SD) age of 66.0 (6.3) years and a FEV1 of 47.1 (18.9) % predicted were randomized to conventional pulmonary rehabilitation (n=20) and conventional pulmonary rehabilitation plus breathing retraining (n=20).
|
In order to train effortless diaphragmatic breathing techniques the biofeedback loop starts at the sensor that measures the patient's breathing rhythm at both umbilical and abdominal level.
The sensor is connected to an amplifier that converts the electrical impulses into acoustical and visual outputs.
Patients were encouraged to regulate their breathing patterns at a 10-20% slower respiration rate resulting in increased tidal volumes.
Furthermore, the patients were encouraged to reduce dynamic hyperinflation by completing the expiration prior to the initiation of the next breath while using pursed-lips breathing.
Patients were trained to breath as comfortable as possible with predominant abdominal expansion during the inhalation and smooth abdominal contraction during exhalation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
cardiopulmonary exercise capacity
|
6-minute walking distance, 6MWD
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
|---|---|
|
pulmonary function
|
pulmonary function (FEV1)
|
|
quality of life
|
health related quality of life (chronic respiratory questionnaire, CRQ)
|
|
autonomic function
|
cardiac autonomic function (rMSSD)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Helmut Teschler, Prof. Dr. dipl Ing, Ruhlrandklink Essen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDAAA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance
Clinical Trials on respiratory biofeedback
-
Seoul National University Bundang HospitalGyeongsang National University HospitalActive, not recruiting
-
University of California, DavisUC Davis MIND Institute; UC Davis, Mini-Grant GeriatricsCompletedHypertension | FXTASUnited States
-
Washington University School of MedicineCompletedVocal Cord Dysfunction | Paradoxical Vocal Fold MotionUnited States
-
Klick Inc.Completed
-
L. Eugene ArnoldNational Institute of Mental Health (NIMH); Brain Resource CenterCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Technische Universität DresdenMichael J. Fox Foundation for Parkinson's Research; University Hospital Carl...CompletedAutonomic Dysfunction | Acute Ischaemic StrokeGermany
-
Badr UniversityCompletedFecal Incontinence in ChildrenEgypt
-
The Hong Kong Polytechnic UniversityKwong Wah HospitalCompleted
-
Icahn School of Medicine at Mount SinaiCompletedMajor Depressive DisorderUnited States
-
New York UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Syracuse... and other collaboratorsCompletedSpeech Sound DisorderUnited States